1974

Asahi Medica Co.Ltd established with ¥100 million capital.

1975

Construction of Japan's largest dialyzer plant begins in Oita.

1976

Capital increased to ¥400 million

1977

Ascites filtration system for intravenous reinjection therapies developed

1978

European office opens.

1979

Hemosorba adsorption column manufacturing and sales begin.

1981

Plasmaflo plasma separator and Plasorba plasma perfusion column manufacturing and sales begin.

Asahi Medical GmbH established in Frankfurt,Germany.

1983

PNF blood purifier manufacturing begins.

1984

Cascadeflo membrane plasma component separator manufacturing and sales begin.

Plasauto system sales begin.

1985

Sepacell R blood transfusion leukocyte reduction filter overseas manufacturing and sales begin.

1986

Immusorba PH immunoadsorption column manufacturing and sales begin.

Oita research and development laboratory opens

1988

Plasorba selective plasma component adsorbing apparatus manufacturing and sales begin

Sepacell R blood transfusion leukocyte removal filter domestic sales begin

1989

Immusorba TR immunoadsorption column manufacturing and sales begin.

1990

Continuous Renal Replacement hemofilter manufacturing and sales begin.

1991

Capital increased to ¥800 million.

1992

Fuji equipment development center opens.

1994

Construction of APS spinning plant in Nobeoka begins.

Finecell microaggregate removal filter manufacturing and sales begin.

IS09001 and CE Marking certification obtained.

1995

Full-scale sales of APS series polysulfone hollow fiber membrane dialyzers begin.

1996

Chicago office opens.

1997

AM-Bio HX series dialyzer sales begin.

1999

Construct on of automated Sepacell blood transfusion leukocyte reduction filter plant begins.

2001

Construction of APS assembly plant in Oita begins.

Cellsorba E leukocytapheresis column(for ulcerative colitis) manufacturing and sales begin.

2002

Terumo Corporation dialyzer sales division acquired.

Asahi Medical GmbH branch opens in Italy.

2003

Merger of Asahi Emars Co., Ltd. sales subsidiary

Asahi Kasei Medical (Hangzhou) Co., Ltd. established.

ISO13845 certification (Oita & headquarters) Obtained.

2004

Cellsorba CS(for rheumatoid arthritis) manufacturing and sales begin.

IS013845 certification (Nobeoka) obtained.

Asahi Kasei Medical America Inc. established.

Company name changed from Asahi Medical Co., Ltd. to Asahi Kasei Medical Co., Ltd.

2005

Construction of Okatomi spinning plant begins in Nobeoka.

Construction of Rexeed assembly plant begins in Hangzhou.

Planova Division transferred from Asahi Kasei Pharma Corp.

2007

Apheresis Technology Square opens.

Asahi Kasei Medical Co., Ltd. reorganized and Asahi Kasei Kuraray Co., Ltd. established.

2008

EVOH hollow fiber membrane manufacturing begins.

Headquarters moved to new location (Jinbocho Mitsui Bldg.).

Asahi Kasei Medical Trading (Korea) Co., Ltd. established.

2012

Integration of Asahi Kasei Kuraray Medical Co., Ltd. and Asahi Kasei Medical Co., Ltd.

2013

Asahi Kasei Medical MT Corp. established.

2016

Completion of new spinning plant for Planova BioEX filters in Oita.

2018

Headquarters moved to new location (Hibiya Mitsui Tower).

2019

Acquisition of Virusure GmbH (Austria).

2020

Asahi Kasei Bioprocess (Shanghai) Co., Ltd. established.

2021

Acquisition of Bionique Testing Laboratories, Inc.

2022

Acquisition of Bionova Scientific, Inc.

*APS = Polysulfone hollow fiber membrane artificial kidney.